Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 3,480 | 685 | 3,786 | 668 | 236 |
| Gross Profit | 3,480 | 685 | 3,786 | 668 | 236 |
| Operating Expenses | 16,920 | 17,324 | 28,566 | 15,010 | 11,601 |
| Operating Income | -13,440 | -16,639 | -24,780 | -14,342 | -11,365 |
| Other Income | 67 | 101 | 1,941 | 118 | 106 |
| Pre-tax Income | -13,373 | -16,538 | -22,839 | -14,224 | -11,259 |
| Income Tax | N/A | N/A | -939 | N/A | -228 |
| Net Income Continuous | -13,373 | -16,538 | -21,900 | -14,224 | -11,031 |
| Net Income | $-13,373 | $-16,538 | $-21,900 | $-14,224 | $-11,031 |
| EPS Basic Total Ops | -0.34 | -0.42 | -0.43 | -0.36 | -0.50 |
| EPS Basic Continuous Ops | -0.34 | -0.42 | -0.43 | -0.36 | -0.50 |
| EPS Diluted Total Ops | -0.34 | -0.42 | -0.43 | -0.36 | -0.50 |
| EPS Diluted Continuous Ops | -0.34 | -0.42 | -0.43 | -0.36 | -0.50 |
| EBITDA(a) | $-12,801 | $-15,912 | $-6,332 | $-13,568 | $-10,489 |